BSE: LAURUSLABS - Laurus Labs Limited

六个月盈利: +22.07%
股息率: +0.35%

促销时间表 Laurus Labs Limited

先进的时间表 简单图表
Financial Markets by TradingView

关于公司 Laurus Labs Limited

Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides oral solid formulations for ARVs, anti-diabetic, cardiovascular, and PPIs.

更多详情
In addition, the company offers contract development and manufacturing organizational services; and biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. Further, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

ISIN INE947Q01028
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.248
Дивиденд ао 0.8
Сайт https://www.lauruslabs.com
Цена ао 558.8
每日价格变化: +1.54% (558.8)
每周价格变化: -7.39% (612.7)
每月价格变化: -1% (573.15)
3个月内价格变化: +17.78% (481.75)
六个月内的价格变化: +22.07% (464.8)
每年价格变化: +36.81% (414.75)
3年内价格变化: +7.92% (525.75)
5年内价格变化: +67.2% (339.35)
10年价格变化: 0% (567.4)
年初以来价格变化: +16% (489.15)
所有参数

低估

姓名 意义 年级
P/S 4.47 4
P/BV 5.44 2
P/E 139.4 1
EV/EBITDA 14.08 7
全部的: 4.5

效率

姓名 意义 年级
ROA, % 1.91 1
ROE, % 3.91 1
全部的: 2

股息

姓名 意义 年级
Div yield, % 0.3494 0.88
DSI 0.8571 8.57
全部的: 3.3

责任

姓名 意义 年级
Debt/EBITDA 1.57 7
全部的: 6.8

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 76.63 8
盈利能力 Ebitda, % 188.31 10
盈利能力 EPS, % -15.58 0
全部的: 3.6
更多详情

ETF 分享, % 本年盈利能力, % 股息, %
iShares MSCI India Small-Cap ETF 0.47272 0.4625 0.96163
iShares MSCI Emerging Markets Small-Cap ETF 0.14838 7.67 2.7853
Franklin FTSE India ETF 0.12135 20.52 1.25133
WisdomTree India Earnings Fund 0.11416 5.23 1.65591
Dimensional Emerging Markets Core Equity 2 ETF 0.07105 15.96 3.34087
WisdomTree Emerging Markets SmallCap Dividend Fund 0.04081 1.35 5.00999
Avantis Emerging Markets Equity ETF 0.03524 8.77 3.60513
Avantis Emerging Markets Value ETF 0.03274 14.12 4.22231
Franklin FTSE Asia ex Japan ETF 0.03027 14.43 2.66768
WisdomTree Global ex-U.S. Quality Dividend Growth Fund 0.01699 9.11 2.73928
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund 0.01631 12.46 3.59676
SPDR Portfolio Emerging Markets ETF 0.01552 11.59 3.1879
SPDR Portfolio MSCI Global Stock Market ETF 0.01304 17.99 2.19607
Dimensional World ex U.S. Core Equity 2 ETF 0.01011 13.06 3.62488
Vanguard ESG International Stock ETF 0.01 6.39 3.07501
iShares Core MSCI Total International Stock ETF 0.00853 6.4 3.25258

导师 职称 支付 出生年份
Dr. Satyanarayana Chava M.Sc., Ph.D. CEO & Whole Time Director 186.44M 1961 (64 年)
Mr. Vantaram Venkata Ravi Kumar Dip in Mgmt., DIS, F.C.M.A. CFO & Whole-Time Director 49.65M 1965 (60 年)
Mr. B. V. R. K. Suryadevara Srinivasa Rao Executive Vice President of Manufacturing & Operations N/A 1968 (57 年)
Mr. Narasimha Rao Chava Executive Vice President of Human Resources N/A 1968 (57 年)
Dr. Lakshmana Rao Venkata Chunduru M.Sc., Ph.D. Head of Quality & Executive Director 33M 1962 (63 年)
Mr. Srinivasa Rao Suryadevara B.Sc, M.Sc. Executive Vice President of Manufacturing N/A 1963 (62 年)
Mr. Chagarlamudi Sita Ramaiah Executive Vice President of Finance N/A 1973 (52 年)
Mr. Dammalapati Venkata Lakshmi Narasimha Rao Executive Vice President of Synthesis N/A 1969 (56 年)
Mr. Krishna Chaitanya Chava Executive VP, Head of Synthesis & Ingredients and Executive Director N/A 1990 (35 年)
Mr. Rajaram Iyer M.B.A. Executive Vice President of Portfolio Management 1974 (51 年)

地址: India, Hyderabad, Serene Chambers - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.lauruslabs.com